Search Results 291-300 of 16691 for alt

1. PKCι & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer - Mayo Clinic

   ... [ALT]) ≤ 3 x ULN or SGOT (AST) and SGPT (ALT) ≤ 5 x ULN is acceptable if liver has tumor involvement; Eastern Cooperative Oncology Group (ECOG) performance ...

2. A Study of XmAb ®18087 in Subjects With NET and GIST - Mayo Clinic

   Alanine aminotransferase (ALT) ≥ 3 × ULN, or if subject has known liver metastases, ALT ≥ 7 × ULN. Estimated creatinine clearance < 50 mL/min calculated ...

3. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

   ... (ALT) or aspartate aminotransferase (AST) >3 × the upper limit of normal (ULN), f) Alkaline phosphatase >3 × ULN, g) Serum creatinine >2 × ULN; Antibiotic use ...

4. Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System - Mayo Clinic

   AST and ALT < 2 times ULN for age; Shortening fraction of ≥ 27% by echocardiogram; Ejection fraction of ≥ 47% by radionuclide angiogram; No evidence of ...

5. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   SGPT (ALT) ≤ 3 x ULN; Creatinine ≤1.5 x ULN. Negative pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only. Patient ...

6. Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents - Mayo Clinic

   AST (SGOT) and ALT (SGPT) ≤ 3 x ULN. Patient must be disease free of prior malignancies for at least 5 years with exception of currently treated basal cell ...

7. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   - Alanine Aminotransferase (ALT) < 5 x ULN; - Serum albumin ≥ 3.5 g/dL; - Serum Alkaline Phosphatase (ALP) ≤ 2 x ULN. - BMI ≥ 23 kg/m^2 at screening. Key ...

8. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 x ULN. Acute or chronic liver disease. Known hypersensitivity to inactive ingredients ...

9. A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 * ULN. Calculated creatinine clearance ≥ 30 mL/min. Exclusion Criteria: Multiple ...

10. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Adequate biochemistry laboratory results (AST/SGOT and ALT/SGPT ≤ 3.0 x upper limit of normal; bilirubin ≤ 2.0 mg/dL; creatinine clearance of ≥ 40 mL/min).